Lundbeck’s CNS Investments Are Delivering Returns
The Danish company’s top line grew by 14% in 2024, driven by strong growth of brands like Rexulti, Brintellix and Vyepti, with continued growth expected.
The Danish company’s top line grew by 14% in 2024, driven by strong growth of brands like Rexulti, Brintellix and Vyepti, with continued growth expected.